, Philippines
/Pixabay

Philippines’ pre-need industry premiums surge 7.3% YoY in 2023

The industry witnessed a 385% rise in net income.

The Philippines’ total premium income collected by pre-need companies reached ₱22.7b by the end of 2023, marking a 7.3% year-on-year (YoY), data from the Insurance Commission (IC) showed.

Net income in the pre-need industry surged to ₱2.1b in 2023, a remarkable 385% rise from 2022. This significant increase was attributed to higher interest income earned from trust funds, mandated by law for paying pre-need benefits.

The surplus in trust funds of pre-need companies also grew year-on-year, indicating improved capability to fulfil pre-need benefits obligations. As of end-2023, investment in trust funds amounted to ₱128b, surpassing pre-need reserves by ₱5.7b.

ALSO READ: The Philippines’ pre-need industry swells 8.2% YoY in Q3

In terms of financial stability, the total net worth of the pre-need industry reached ₱23.2b, reflecting an 11.2% YoY. Nine pre-need companies reported net worth increases, with one company seeing a notable 32.4% YoY rise.

Data from the IC were compiled from the financial submissions of sixteen pre-need companies, excluding Caritas Financial Plans, Inc., which underwent conservatorship in July 2023.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.